Lataa...
Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2
Activating mutations in KEAP1-NRF2 are frequently found in tumors of the lung, esophagus, and liver, where they are associated with aggressive growth, resistance to cancer therapies, and low overall survival. Despite the fact that NRF2 is a validated driver of tumorigenesis and chemotherapeutic resi...
Tallennettuna:
| Julkaisussa: | Mol Cell Biol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7588872/ https://ncbi.nlm.nih.gov/pubmed/32868290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/MCB.00377-20 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|